Reproductive choices and outcomes after freezing oocytes for medical reasons: A follow-up study

Human Reproduction

Volumn 29, Issue 9, 2014, Pages 1925-1930

  Dahhan, T ^a   Dancet, E A F ^a   Miedema, D V ^a   Van Der Veen, F ^a   Goddijn, M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

fertility preservation; gonadotoxic treatments; oocyte cryopreservation; primary ovarian insufficiency; reproductive choices

Indexed keywords

BLEOMYCIN; DOXORUBICIN; VINBLASTINE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CRYOPRESERVATION; ENDOMETRIOSIS; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HUMAN CELL; INFERTILITY THERAPY; LIVE BIRTH; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OOCYTE CRYOPRESERVATION; OOCYTE RETRIEVAL; OVARIECTOMY; PREGNANCY OUTCOME; SALPINGOOOPHORECTOMY; SPONTANEOUS ABORTION; TREATMENT CONTRAINDICATION; TUMOR SUPPRESSOR GENE; FERTILITY PRESERVATION; REPRODUCTIVE BEHAVIOR; STATISTICS AND NUMERICAL DATA;

ADULT; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; FOLLOW-UP STUDIES; HUMANS; OOCYTES; REPRODUCTIVE BEHAVIOR;

EID: 84906084954     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu137     Document Type: Article

References (29)

1. Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast 2004; 6:446-451. (Pubitemid 39618815)
2. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2013;9:873-881.
3. Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril 2013;6:1496-1502.
4. Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, Friis-Hansen L, Nyboe AA. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod 2013;1:247-255.
5. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;5:1718-1729. (Pubitemid 26134232)
6. Braems G, Denys H, De WO, Cocquyt V, Van den Broecke R. Use of tamoxifen before and during pregnancy. Oncologist 2011;11:1547-1551.
7. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med 2000;15:1086-1094.
8. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective newapproach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008;5:268-273.
9. DaviesC, Godwin J, Gray R, ClarkeM, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011;9793:771-784.
10. Garcia-Velasco JA, Domingo J, Cobo A, Martinez M, Carmona L, Pellicer A. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril 2013;7:1994-1999.
11. Gonçalves V, Sehovic I, Quinn G. Childbearing attitudes and decisions of young breast cancer survivors: a systematic review. Hum Reprod Update 2013;20:279-292.
12. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril 2010;2:391-396.
13. Harper J, Magli MC, Lundin K, Barratt CL, Brison D. When and how should new technology be introduced into the IVF laboratory? Hum Reprod 2012; 27:303-313.
14. Heck KE, Schoendorf KC, Ventura SJ, Kiely JL. Delayed childbearing by education level in the United States, 1969-1994. Matern Child Health J 1997;2:81-88.
15. Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril 2013; 5:1343-1349.
16. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 3:300-308. (Pubitemid 41269568)
17. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;19:2500-2510.
18. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hematooncological neoplasias and other cancers. Leuk Lymphoma 1999;1-2:65-76. (Pubitemid 29116395)
19. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;4:727-739.
20. Nielsen SN, Andersen AN, Schmidt KT, Rechnitzer C, Schmiegelow K, Bentzen JG, Larsen EC. A 10-year follow up of reproductive function in women treated for childhood cancer. Reprod Biomed Online 2013; 2:192-200.
21. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online 2009;6:769-776.
22. Purushothaman R, Lazareva O, Oktay K, Ten S. Markers of ovarian reserve in young girls with Turner's syndrome. Fertil Steril 2010;4:1557-1559.
23. Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, Remohi J, Ragni G, Ubaldi FM. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod 2012;6:1606-1612.
24. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 2010;1:66-73.
25. Schover LR. Motivation for parenthood after cancer: a review. J Natl Cancer Inst Monogr 2005;34:2-5.
26. Schmidt KT, Nyboe AA, GreveT, Ernst E, Loft A, Yding AC. Fertility in cancer patients after cryopreservation of one ovary. Reprod Biomed Online 2013; 3:272-279.
27. Stoop D, Nekkebroeck J, Devroey P.Asurveyon the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod 2011;3:655-661.
28. Sybert VP. Phenotypic effects of mosaicism for a 47, XXX cell line in Turner syndrome. J Med Genet 2002;3:217-220.
29. Tarani L, Lampariello S, Raguso G, Colloridi F, Pucarelli I, Pasquino AM, Bruni LA. Pregnancy in patients with Turner's syndrome: six new cases and review of literature. Gynecol Endocrinol 1998;2: 83-87. (Pubitemid 28230356)